Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
1.790
-0.040 (-2.19%)
At close: Mar 28, 2025, 4:00 PM
1.800
+0.010 (0.55%)
After-hours: Mar 28, 2025, 7:58 PM EDT
Cronos Group Market Cap
Cronos Group has a market cap or net worth of $685.40 million as of March 28, 2025. Its market cap has decreased by -11.01% in one year.
Market Cap
685.40M
Enterprise Value
-130.18M
1-Year Change
-11.01%
Ranking
Category
Stock Price
$1.79
Market Cap Chart
Since February 27, 2018, Cronos Group's market cap has decreased from $1.14B to $685.40M, a decrease of -39.78%. That is a compound annual growth rate of -6.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 684.70M | -11.33% |
| Dec 31, 2024 | 772.20M | -3.05% |
| Dec 29, 2023 | 796.50M | -17.14% |
| Dec 30, 2022 | 961.30M | -34.04% |
| Dec 31, 2021 | 1.46B | -41.04% |
| Dec 31, 2020 | 2.47B | -6.25% |
| Dec 31, 2019 | 2.64B | 42.01% |
| Dec 31, 2018 | 1.86B | 63.14% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |